title: Bilateral Choroidal Metastases from Prostate Cancer revealed in a patient under Abiraterone - Fourteen years after diagnosis.
abstract: Choroidal metastasis from prostate cancer is very rare and usually presents late during the disease. Since 2010, many new drugs were approved in the treatment of castrationresistant prostate cancer, including Abiraterone acetate. We report a case of bilateral choroidal metastases from prostate cancer 3 months after the initiation of Abiraterone. Abiraterone was not efficient in controlling the progression of the disease in this case, especially the choroidal metastasis. More case reports are essential in order to evaluate the role of Abiraterone in controlling choroidal metastases from prostate adenocarcinoma.
authors.affiliation: Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
authors.forename: H R
authors.initials: HR
authors.lastname: Kourie
authors.affiliation: Ophthalmology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
authors.forename: J
authors.initials: J
authors.lastname: Antoun
authors.affiliation: Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
authors.forename: F
authors.initials: F
authors.lastname: Bteich
authors.affiliation: Ophthalmology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
authors.forename: A
authors.initials: A
authors.lastname: Jalkh
authors.affiliation: Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
authors.forename: M
authors.initials: M
authors.lastname: Ghosn
mesh_terms: D000736:Androstenes / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000736:Androstenes; D000970:Antineoplastic Agents; C089740:abiraterone
keywords: abiraterone; metastases.; prostate cancer